Pfizer Begins Testing Omicron-Matched COVID Shots in Adults

NEW YORK (AP) – Pfizer and BioNTech have begun studying a COVID-19 vaccine tweaked to match to the omicron variant in healthy adults.

COVID-19 vaccine makers have been updating their shots in case global health authorities decide a change is needed.

The study announced Tuesday will include more than 1,400 volunteers ages 18 to 55. Most already are vaccinated and will get boosters of the omicron-based vaccine or the original version. Some unvaccinated volunteers will get three omicron-based doses.

The original vaccines still offer good protection against severe illness and death. And a booster improves the chances of avoiding even a milder infection.

By Lauran Neergaard, Associated Press

About Brendan Fitzpatrick

Brendan, a recent graduate from the University of Massachusetts Amherst, is one of the newest members of the NewsCenter team. When not on the beat, you'll probably find him watching Boston sports.
737 West Main Street
Hyannis, MA 02601
Contact Us | Advertise Terms of Use 
Employment and EEO | Privacy